Literature DB >> 27150257

International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.

Lars Egevad1,2, Brett Delahunt3, John R Srigley4, Hemamali Samaratunga5.   

Abstract

The International Society of Urological Pathology (ISUP) has issued guidelines for the grading of prostate cancer based on a consensus conference held in 2014. The recommendations resulting from the 2014 consensus conference were a further development of 2005 ISUP modified Gleason grading. In the 2014 system, morphological criteria are clarified, including updated definitions of Gleason pattern 4. In addition to the continued reporting of Gleason scores, we also recommend that Gleason scores ≤6, 3 + 4 = 7, 4 + 3 = 7, 8 and 9-10, respectively, be reported as five groups, i.e. ISUP grades 1-5. This new grading system has the dual benefit of predicting patient outcome as well as facilitating patient communication.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Gleason grade; ISUP grade; Prostate cancer; grading

Mesh:

Year:  2016        PMID: 27150257     DOI: 10.1111/apm.12533

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  35 in total

1.  Infection rate and complications after 621 transperineal MRI-TRUS fusion biopsies in local anesthesia without standard antibiotic prophylaxis.

Authors:  K Günzel; A Magheli; E Baco; H Cash; S Heinrich; H Neubert; J Schlegel; M Schostak; T Henkel; P Asbach; S Hinz
Journal:  World J Urol       Date:  2021-04-18       Impact factor: 4.226

2.  Combining weakly and strongly supervised learning improves strong supervision in Gleason pattern classification.

Authors:  Sebastian Otálora; Niccolò Marini; Henning Müller; Manfredo Atzori
Journal:  BMC Med Imaging       Date:  2021-05-08       Impact factor: 1.930

3.  MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia.

Authors:  Irena Abramovic; Borna Vrhovec; Lucija Skara; Alen Vrtaric; Nora Nikolac Gabaj; Tomislav Kulis; Goran Stimac; Dejan Ljiljak; Boris Ruzic; Zeljko Kastelan; Bozo Kruslin; Floriana Bulic-Jakus; Monika Ulamec; Ana Katusic-Bojanac; Nino Sincic
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

4.  Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic study.

Authors:  Kosj Yamoah; Francis A Asamoah; Afua O D Abrahams; Shivanshu Awasthi; James E Mensah; Jasreman Dhillon; Brandon A Mahal; Serigne Magueye Gueye; Mohamed Jalloh; Sahar J Farahani; Priti Lal; Timothy R Rebbeck; Joel Yarney
Journal:  Prostate       Date:  2021-09-16       Impact factor: 4.104

5.  Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer.

Authors:  Yuping Zeng; Xiaoming Leng; Hengbin Liao; Guihua Jiang; Ping Chen
Journal:  Prostate Int       Date:  2022-03-28

6.  Next Generation Quality: Assessing the Physician in Clinical History Completeness and Diagnostic Interpretations Using Funnel Plots and Normalized Deviations Plots in 3,854 Prostate Biopsies.

Authors:  Michael Bonert; Ihab El-Shinnawy; Michael Carvalho; Phillip Williams; Samih Salama; Damu Tang; Anil Kapoor
Journal:  J Pathol Inform       Date:  2017-11-23

7.  17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.

Authors:  Daniel W Lin; Yingye Zheng; Jesse K McKenney; Marshall D Brown; Ruixiao Lu; Michael Crager; Hilary Boyer; Maria Tretiakova; James D Brooks; Atreya Dash; Michael D Fabrizio; Martin E Gleave; Suzanne Kolb; Michael Liss; Todd M Morgan; Ian M Thompson; Andrew A Wagner; Athanasios Tsiatis; Andrea Pingitore; Peter S Nelson; Lisa F Newcomb
Journal:  J Clin Oncol       Date:  2020-03-04       Impact factor: 44.544

8.  MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

Authors:  Michael Ahdoot; Andrew R Wilbur; Sarah E Reese; Amir H Lebastchi; Sherif Mehralivand; Patrick T Gomella; Jonathan Bloom; Sandeep Gurram; Minhaj Siddiqui; Paul Pinsky; Howard Parnes; W Marston Linehan; Maria Merino; Peter L Choyke; Joanna H Shih; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  N Engl J Med       Date:  2020-03-05       Impact factor: 91.245

9.  Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.

Authors:  Michael Deal; Florian Bardet; Paul-Michael Walker; Mathilde Funes de la Vega; Alexandre Cochet; Luc Cormier; Imad Bentellis; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2021-08

10.  PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance.

Authors:  Alex Z Wang; Luke P O’Conno; Nitin K Yerram; Lori Long; Johnathan Zeng; Sherif Mehralivand; Stephanie A Harmon; Amir H Lebastchi; Michael Ahdoot; Patrick T Gomella; Sandeep Gurram; Peter L Choyke; Maria J Merino; Joanna H Shih; Bradford J Wood; Baris Turkbey; Peter A Pinto
Journal:  J Urol       Date:  2020-07-27       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.